Abstract
Background
The local and systemic regulation of the immune system may play important roles in the process of liver metastasis of colorectal carcinoma. The aim of this study was to establish a reproducible experimental liver metastasis model, to identify changes in T cells and cytokines TGF-β1 and IL-10, and to explore a possible mechanism of liver metastasis of colon carcinoma.
Methods
We used a colon carcinoma liver metastasis model, in which different numbers of CT-26 murine colon carcinoma cells (1 × 103, 5 × 103, 1 × 104, 5 × 104, and 1 × 105) were injected into the spleen. The liver and spleen tissues were examined for T cell markers using flow cytometry. Liver tissues were analyzed for IL-10 and transforming growth factor beta 1 (TGF-β1) expression using immunohistochemistry.
Results
Spleen injection of colon carcinoma cells is a reproducible animal model for liver metastases, which resulted in quantity-dependent metastatic growth. We provided a snapshot of the hepatic immune microenvironment in the mouse liver metastasis model. Injection of A large number of tumor cells (5 × 104 and 1 × 105) decreased anti-tumor cell counts, such as CD4+ and CD8+ T cells, and increased immune-suppressive cell counts (CD4+CD25+ Treg cells). In addition, the expression levels of immunosuppressive cytokines IL-10 and TGF-β1 were also increased with the number of tumor cells.
Conclusions
Changes in the systemic and local immunological environment contribute to immunological escape mechanisms during liver metastasis of colon carcinoma, and therapies aiming at immune microenvironment may prove a useful strategy in the treatment of metastatic disease in the future.
Similar content being viewed by others
References
Watanabe T, Kobunai T, Yamamoto Y, et al. Prediction of liver metastasis after colorectal cancer using reverse transcription-polymerase chain reaction analysis of 10 genes. Eur J Cancer, 2010; 46: 2119–26.
Kim J C, Roh S A, Kim H C, Coexpression of carcinoembryonic antigen and E-cadherin in colorectal adenocarcinoma with liver metastasis. J Gastrointest Surgs, 2003; 7:931–380.
Anaya DA, Becker NS, Abraham NS. Global graying, colorectal cancer and liver metastasis: new implications for surgical management. Crit Rev Oncol Hematol, 2011; 77: 100–8.
de Jong GM, Aarts F, Hendriks T, et al. Animal models for liver metastases of colorectal cancer: research review of preclinical studies in rodents. J Surg Res, 2009; 154: 167–76.
Nathan H, de Jong MC, Pulitano C, et al. Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients. J Am Coll Surg, 2010; 210:755–66.
Sasaki A, Iwashita Y, Shibata K, et al. Analysis of preoperative prognostic factors for long-term survival after hepatic resection of liver metastasis of colorectal carcinoma. J Gastrointest Surg, 2005; 9:374–380.
Grimm M, Gasser M, Bueter M, et al. Evaluation of immunological escape mechanisms in a mouse model of colorectal liver metastases. BMC Cancer, 2010; 10: 82.
Kelly AM, Golden-Mason L, Traynor O, et al. Changes in hepatic immunoregulatory cytokines in patients with metastatic colorectal carcinoma: implications for hepatic anti-tumor immunity. Cytokine, 2006; 35:171–9.
Dunne J, Lynch S, O'Farrelly C, et al. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. J Immunol, 2001; 167: 3129–38.
Lutsiak ME, Semnani RT, De Pascalis R, et al. Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood, 2005; 105: 2862–8.
Bierie B, Moses HL. Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine & Growth Factor Reviews, 2010; 21: 49–59.
Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature, 2003; 425: 577–84.
Yang L, Pang Y, Moses HL. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol, 2010; 31: 220–7.
Herbeuval JP, Lelievre E, Lambert C, et al. (2004) Recruitment of STAT3 for production of IL-10 by colon carcinoma cells induced by macrophage-derived IL-6. J Immunol, 172: 4630–6.
Liu HY, Huang ZL, Yang GH, et al. Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model. World J Gastroenterol, 2008. 14(48): p. 7386–91.
Kollmar O, Schilling MK, Menger MD. Experimental liver metastasis. Standards for local cell implantation to study isolated tumor growth in mice. Clin Exp Metastasis 2004; 5 :453–460.
Disis ML, Bernhard H, Jaffee EM. Use of tumor-responsive T cells as cancer treatment. Lancet, 2009; 373: 673–83.
Ostrand-Rosenberg S. Immune surveillance: a balance between protumor and antitumor immunity. Current Opinion in Genetics & Development, 2008; 18:11–8.
de la Cruz-Merino, L, et al. Immune microenvironment in colorectal cancer: a new hallmark to change old paradigms. Clin Dev Immunol, 2011. 2011: p. 174149.
Folprecht G, Gruenberger T, Bechstein WO. Tumor response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol, 2010; 11: 38–47.
Midgley R, Kerr D. Immunotherapy for colorectal cancer: a challenge to clinical trial design. Lancet Oncol, 2000; 1: 159–68.
Almeida AR, et al. CD4(+)CD25(+) Treg regulate the contribution of CD8(+) T-cell subsets in repopulation of the lymphopenic environment. Eur J Immunol, 2010; 40:3478–88.
Zanin-Zhorov A, Ding Y, Kumari S, et al. Protein kinase C-theta mediates negative feedback on regulatory T cell function. Science, 2010; 328:372–6.
Bierie B, Moses HL. Tumor microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer, 2006; 6: 506–20.
Nagaraj NS, Datta PK. Targeting the transforming growth factor-beta signaling pathway in human cancer. Expert Opin Investig Drugs, 2010; 19: 77–91.
Acknowledgments
This study was supported by the National Natural Scientific Foundation of China grant 81072046 and the Research Fund for the Doctoral Program of Higher Education of China 20100171110075 to Dr. P. Lan and Medical Scientific Research Foundation of Guangdong Province (#B2012149).
Author information
Authors and Affiliations
Corresponding author
Additional information
Xiaoming Huang and Yifeng Zou contributed equally to this paper.
Rights and permissions
About this article
Cite this article
Huang, X., Zou, Y., Lian, L. et al. Changes of T Cells and Cytokines TGF-β1 and IL-10 in Mice During Liver Metastasis of Colon Carcinoma: Implications for Liver Anti-tumor Immunity. J Gastrointest Surg 17, 1283–1291 (2013). https://doi.org/10.1007/s11605-013-2194-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-013-2194-5